Robert E W Hancock Selected Research

mastoparan

1/2020	MDA-MB-231 Breast Cancer Cells Resistant to Pleurocidin-Family Lytic Peptides Are Chemosensitive and Exhibit Reduced Tumor-Forming Capacity.
12/2016	Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert E W Hancock Research Topics

Disease

115	Infections 11/2022 - 10/2001
41	Inflammation (Inflammations) 01/2022 - 01/2004
19	Bacterial Infections (Bacterial Infection) 11/2021 - 10/2006
14	Abscess 01/2022 - 10/2016
13	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 12/2003
9	Sepsis (Septicemia) 01/2022 - 01/2005
7	Communicable Diseases (Infectious Diseases) 11/2021 - 09/2006
5	Whooping Cough (Pertussis) 01/2022 - 03/2009
5	Neoplasms (Cancer) 01/2020 - 11/2003
4	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2015
4	Pseudomonas Infections 02/2015 - 08/2010
3	Urinary Tract Infections (Urinary Tract Infection) 08/2021 - 01/2017
3	Persistent Infection 01/2021 - 08/2005
3	Vasculitis (Vasculitides) 01/2021 - 01/2018
3	Leukemia 01/2020 - 12/2016
3	Tuberculosis (Tuberculoses) 01/2020 - 01/2013
3	Necrosis 07/2018 - 01/2009
3	Hemolysis 07/2018 - 11/2003
3	Starvation 01/2018 - 07/2009
3	Pneumonia (Pneumonitis) 01/2013 - 06/2008
2	Edema (Dropsy) 01/2020 - 11/2017
2	Otitis 01/2020 - 11/2017
2	Asthma (Bronchial Asthma) 01/2020 - 04/2013
2	Salmonella Infections (Salmonellosis) 10/2019 - 04/2005
2	Hypoxia (Hypoxemia) 01/2018 - 01/2009
2	Wounds and Injuries (Trauma) 01/2018 - 01/2012
2	Burns 01/2018 - 02/2011
2	Body Weight (Weight, Body) 01/2017 - 01/2011
2	Lung Diseases (Lung Disease) 01/2014 - 12/2012
2	Muscle Cramp (Cramp) 02/2013 - 09/2008
2	African Trypanosomiasis (Nagana) 01/2009 - 01/2003
2	Chronic Granulomatous Disease 10/2008 - 04/2007

Drug/Important Bio-Agent (IBA)

68	Peptides (Polypeptides)IBA 11/2021 - 03/2002
40	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2003
21	Antimicrobial Cationic PeptidesIBA 11/2021 - 01/2003
18	Antimicrobial PeptidesIBA 11/2022 - 07/2005
16	CytokinesIBA 01/2022 - 06/2007
10	CathelicidinsIBA 01/2020 - 01/2004
9	Pharmaceutical PreparationsIBA 11/2022 - 01/2012
9	innate defense regulating peptide 1018IBA 12/2020 - 01/2012
8	VaccinesIBA 01/2022 - 02/2011
8	IDR 1002IBA 01/2019 - 03/2010
6	ChemokinesIBA 01/2020 - 02/2006
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2013
5	LipopolysaccharidesIBA 01/2020 - 01/2011
5	MucinsIBA 01/2020 - 01/2012
5	Anti-Infective Agents (Microbicides)IBA 12/2019 - 12/2008
4	Amino Acids FDA Link 11/2021 - 02/2015
4	SolutionsIBA 11/2018 - 01/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 02/2006
4	AminoglycosidesIBA 05/2011 - 02/2007
4	Polymyxin B (Aerosporin)FDA LinkGeneric 08/2010 - 08/2008
3	Vaccine AdjuvantsIBA 01/2022 - 03/2009
3	LipidsIBA 01/2022 - 11/2003
3	PolymersIBA 11/2021 - 12/2015
3	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2017
3	Peptide Hydrolases (Proteases)FDA Link 08/2020 - 08/2014
3	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2012
3	NitrogenIBA 01/2020 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2006
3	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2018 - 08/2005
3	Meropenem (Merrem)FDA LinkGeneric 01/2018 - 07/2015
3	Oxygen (Dioxygen)IBA 01/2018 - 01/2017
3	IronIBA 01/2017 - 07/2009
3	Biological ProductsIBA 01/2016 - 12/2013
3	Virulence Factors (Pathogenicity Factors)IBA 01/2015 - 08/2008
3	EndotoxinsIBA 11/2014 - 10/2008
3	NF-kappa B (NF-kB)IBA 04/2007 - 02/2006
2	PeptoidsIBA 11/2022 - 01/2016
2	SphingomyelinsIBA 01/2022 - 07/2018
2	Liposomes (Liposome)IBA 01/2022 - 07/2018
2	Colistin (Coly-Mycin)FDA Link 01/2020 - 08/2010
2	pleurocidinIBA 01/2020 - 12/2015
2	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2013
2	mastoparanIBA 01/2020 - 12/2016
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2019 - 01/2018
2	Vancomycin FDA LinkGeneric 01/2018 - 04/2007
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2016
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2018 - 01/2017
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2017 - 01/2010
2	Guanosine TetraphosphateIBA 01/2017 - 10/2016
2	Adenosine Monophosphate (AMP)IBA 01/2017 - 12/2015
2	Phosphotransferases (Kinase)IBA 01/2017 - 03/2014
2	Interferon Type IIBA 01/2017 - 12/2009
2	Phosphates (Orthophosphate)IBA 01/2017 - 09/2012
2	InterleukinsIBA 01/2017 - 08/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 07/2013
2	Azithromycin (Zithromax)FDA LinkGeneric 06/2014 - 05/2011
2	bactenecinIBA 11/2013 - 09/2008
2	TitaniumIBA 08/2013 - 12/2010
2	DNA (Deoxyribonucleic Acid)IBA 10/2011 - 08/2005
2	Daptomycin FDA Link 08/2011 - 07/2004
2	LipopeptidesIBA 08/2011 - 07/2004
2	indolicidinIBA 09/2008 - 08/2008
1	Pertussis VaccineIBA 01/2022
1	InterferonsIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 11/2021
1	Biocompatible Materials (Biomaterials)IBA 11/2021

Therapy/Procedure

29	Therapeutics 01/2022 - 07/2005
3	Catheters 08/2021 - 01/2017